# Exploratory Study to Assess the Efficacy and Safety of TC-5214 in the Treatment of Subjects With Palmar Hyperhidrosis

> **NCT03404570** · PHASE2 · COMPLETED · sponsor: **Atacama Therapeutics** · enrollment: 60 (actual)

## Conditions studied

- Palmar Hyperhidrosis

## Interventions

- **DRUG:** Dexmecamylamine HCl
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03404570
- **Lead sponsor:** Atacama Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-21
- **Primary completion:** 2019-01-18
- **Final completion:** 2019-01-18
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2019-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03404570

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03404570, "Exploratory Study to Assess the Efficacy and Safety of TC-5214 in the Treatment of Subjects With Palmar Hyperhidrosis". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03404570. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*